Core Laboratories N.V. (CLB) |
| 10.225 0.355 (3.6%) 07-30 12:18 |
| Open: | 10.305 |
| High: | 10.44 |
| Low: | 9.95 |
| Volume: | 274,956 |
| Market Cap: | 471(M) |
| PE Ratio: | 15.04 |
| Exchange: | New York Stock Exchange |
| Industry: | Oil & Gas Equipment & Services |
| Sector: | Energy |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 12.27 |
| Resistance 1: | 11.32 |
| Pivot price: | 11.22 |
| Support 1: | 9.80 |
| Support 2: | 8.15 |
| 52w High: | 20.36 |
| 52w Low: | 9.72 |
Core Laboratories N.V. (CLB) is a global provider to the oil and gas sector, delivering specialized services and products for characterizing subterranean reservoirs and optimizing hydrocarbon extraction. The company's operations are distinctly segmented into Reservoir Description and Production Enhancement. The Reservoir Description division meticulously analyzes petroleum reservoir rock, fluid, and gas samples. This detailed scientific examination aims to boost the yield and enhance the recovery of oil and gas from clients' reservoirs. Offerings in this segment encompass comprehensive laboratory analysis and on-site field evaluations to determine the properties of crude oil and refined products, alongside performing proprietary and collaborative industry research studies. Conversely, the Production Enhancement segment furnishes an array of services and products vital for well completions, perforations, stimulation processes, and general production activities. This includes providing integrated diagnostic tools designed to assess the efficacy of well completions and to devise strategies for more effective enhanced oil recovery initiatives. Core Laboratories markets and sells its solutions through diverse channels, including direct sales representatives, educational seminars, industry trade exhibitions, print advertising, and a network of distributors. Established in 1936, the company boasts a significant international presence, conducting operations in approximately 50 countries, with its corporate headquarters situated in Amstelveen, the Netherlands.
| EPS | 0.610 |
| Book Value | 5.840 |
| PEG Ratio | 1.44 |
| Gross Profit | 2.268 |
| Profit Margin (%) | 5.53 |
| Operating Margin (%) | 1.62 |
| Return on Assets (ttm) | 4.9 |
| Return on Equity (ttm) | 11.1 |
Thu, 30 Jul 2026
Earnings call transcript: Core Laboratories misses Q2 2026 EPS forecast - Investing.com
Thu, 30 Jul 2026
Core Laboratories Inc. (NYSE:CLB) Declares $0.01 Quarterly Dividend - MarketBeat
Thu, 30 Jul 2026
Why Is Core Laboratories (NYSE:CLB) in NYSE Composite News Flow? - Kalkine Media
Thu, 30 Jul 2026
CLB Looks 44.9% Undervalued on GF Value™ - GuruFocus
Wed, 29 Jul 2026
Core Laboratories (NYSE:CLB) Issues Earnings Results - MarketBeat
Wed, 29 Jul 2026
Core Laboratories (NYSE:CLB) Releases Q3 2026 Earnings Guidance - MarketBeat
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |